CapsoVision (CV) Competitors $4.00 +0.15 (+3.90%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock CV vs. AXGN, SIBN, BVS, ZIMV, AVNS, SMLR, KIDS, CBLL, TMCI, and DCTHShould you be buying CapsoVision stock or one of its competitors? The main competitors of CapsoVision include AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), Semler Scientific (SMLR), OrthoPediatrics (KIDS), CeriBell (CBLL), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. CapsoVision vs. Its Competitors AxoGen SiBone Bioventus ZimVie AVANOS MEDICAL Semler Scientific OrthoPediatrics CeriBell Treace Medical Concepts Delcath Systems CapsoVision (NASDAQ:CV) and AxoGen (NASDAQ:AXGN) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk. Does the media refer more to CV or AXGN? In the previous week, AxoGen had 1 more articles in the media than CapsoVision. MarketBeat recorded 7 mentions for AxoGen and 6 mentions for CapsoVision. AxoGen's average media sentiment score of 0.83 beat CapsoVision's score of -0.02 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CapsoVision 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AxoGen 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is CV or AXGN more profitable? CapsoVision has a net margin of 0.00% compared to AxoGen's net margin of -2.29%. CapsoVision's return on equity of 0.00% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets CapsoVisionN/A N/A N/A AxoGen -2.29%-4.43%-2.34% Do analysts recommend CV or AXGN? CapsoVision currently has a consensus price target of $5.50, suggesting a potential upside of 37.50%. AxoGen has a consensus price target of $26.00, suggesting a potential upside of 67.85%. Given AxoGen's higher probable upside, analysts plainly believe AxoGen is more favorable than CapsoVision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CapsoVision 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50AxoGen 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation and earnings, CV or AXGN? CapsoVision has higher earnings, but lower revenue than AxoGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCapsoVisionN/AN/AN/AN/AN/AAxoGen$187.34M3.80-$9.96M-$0.10-154.90 Do insiders and institutionals hold more shares of CV or AXGN? 80.3% of AxoGen shares are held by institutional investors. 2.8% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryAxoGen beats CapsoVision on 7 of the 12 factors compared between the two stocks. Get CapsoVision News Delivered to You Automatically Sign up to receive the latest news and ratings for CV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CV vs. The Competition Export to ExcelMetricCapsoVisionSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$185.36M$170.36M$2.56B$9.79BDividend YieldN/AN/A2.55%4.10%P/E RatioN/A2.4522.1625.27Price / SalesN/A17.5278.2688.61Price / CashN/A4.1523.4628.45Price / BookN/A1.6037.756.00Net IncomeN/A-$66.04M$31.01M$265.34M7 Day Performance-2.68%0.35%0.82%2.79%1 Month Performance-12.09%-9.37%0.89%1.51%1 Year PerformanceN/A154.34%29.00%25.40% CapsoVision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVCapsoVisionN/A$4.00+3.9%$5.50+37.5%N/A$185.36MN/A0.0090News CoverageEarnings ReportAnalyst RevisionAXGNAxoGen3.0681 of 5 stars$14.93+0.2%$26.00+74.1%+27.3%$686.97M$187.34M-149.29450Short Interest ↑SIBNSiBone4.3673 of 5 stars$15.46+1.0%$23.67+53.1%+11.5%$666.96M$167.18M-27.61350BVSBioventus1.3482 of 5 stars$7.37+0.4%N/AN/A$609.34M$573.28M14.741,200ZIMVZimVie0.6461 of 5 stars$18.85+0.1%$17.75-5.8%+5.5%$531.59M$449.75M-26.931,770Short Interest ↑AVNSAVANOS MEDICAL3.0742 of 5 stars$11.18+2.0%N/A-52.1%$519.70M$687.80M-1.112,227Insider TradeShort Interest ↑SMLRSemler Scientific3.3553 of 5 stars$33.84-3.7%$81.75+141.6%+15.7%$501.00M$42.98M13.93120Gap UpKIDSOrthoPediatrics4.0209 of 5 stars$19.19+0.3%$34.14+77.9%-29.9%$481.17M$204.73M-10.72200CBLLCeriBell2.3265 of 5 stars$12.31+4.4%$32.14+161.1%N/A$451.33M$65.44M-4.12N/ATMCITreace Medical Concepts2.3677 of 5 stars$6.89-0.9%$9.83+42.7%+11.5%$435.26M$209.36M-8.72250DCTHDelcath Systems2.6564 of 5 stars$10.36-1.1%$24.50+136.5%+38.1%$362.40M$70.24M207.2060Short Interest ↑ Related Companies and Tools Related Companies AXGN Alternatives SIBN Alternatives BVS Alternatives ZIMV Alternatives AVNS Alternatives SMLR Alternatives KIDS Alternatives CBLL Alternatives TMCI Alternatives DCTH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CV) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CapsoVision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CapsoVision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access